Declining stem cell function is undoubtedly an important contribution to degenerative aging and age-related mortality. Tissues require the supply of new somatic cells that is generated by stem cells in order to replace losses, repair damage, and maintain function. Unlike stem cells, somatic cells are limited in the number of times they can divide. Turnover of somatic cell populations is a...
Month: <span>December 2021</span>
Post
Keeping the aging brain connected with words and music
by Vibhav Nandagiri, Duke Research Blog Relative location of subcortical white matter fiber tracts (lateral view). Credit: Wikipedia In an era of seemingly endless panaceas for age-based mental decline, navigating through the clutter can be a considerable challenge. However, a team of Duke researchers, led by cognitive neuroscientist Edna Andrews, Ph.D., think they may have found...
Post
What is Known of the Reasons Why Aging Stem Cells Lose their Regenerative Capacity
Declining stem cell function is undoubtedly an important contribution to degenerative aging and age-related mortality. Tissues require the supply of new somatic cells that is generated by stem cells in order to replace losses, repair damage, and maintain function. Unlike stem cells, somatic cells are limited in the number of times they can divide. Turnover of somatic cell populations is a...
Post
When should you go to hospital for a headache? A doctor explains how to tell if it’s an emergency
by Natasha Yates, The Conversation Credit: www.shutterstock.com I waited for hours in emergency last night with this dreadful headache, but eventually gave up and left. Should I have kept waiting at the hospital? This is a surprisingly common scenario I encounter as a general practitioner. If you’re wondering how bad your headache needs to be to go...
Post
Abiraterone could halve risk of prostate cancer death for some patients
by Institute of Cancer Research Credit: CC0 Public Domain Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death from the disease. The researchers suggest that hormone therapy using abiraterone with prednisolone, could significantly reduce prostate cancer deaths and improve outcomes...
Post
Have you fallen for the myth of ‘I can’t draw’? Do it anyway – and reap the rewards
by Darren C. Fisher, The Conversation Credit: Darren Fisher, Author provided Drawing is a powerful tool of communication. It helps build self-understanding and can boost mental health. But our current focus on productivity, outcomes, and “talent” has us thinking about it the wrong way. Too many believe the myth of “I can’t draw”, when in fact...
Post
Sex hormone-binding globulin may be biomarker for CVD risk in men
(HealthDay)—Men with lower concentrations of total testosterone do not have an increased risk for cardiovascular events, while lower concentration of sex hormone-binding globulin (SHBG) is associated with a higher incidence of myocardial infarction (MI), according to a study published online Dec. 28 in the Annals of Internal Medicine. Bu B. Yeap, Ph.D., from the University of...
Post
Medication Therapy Management (MTM)
Hello everyone, This is a follow up email regarding new program called MTM. I hired a pharmacist Dr. Rebecca Choi PharmD clinical pharmacist who helps medication management. This is become necessary because of the overburdening pharmacist due to COVID it used to be that pharmacist would take time to check for drug interactions and with...
Post
Promoting exercise rehabilitation as new and powerful tool for managing symptoms of multiple sclerosis
KESSLER FOUNDATION IMAGE: DR. BRIAN SANDROFF MONITORS A RESEARCH PARTICIPANT IN AN MS EXERCISE STUDY AT KESSLER FOUNDATION. CREDIT: KESSLER FOUNDATION East Hanover, NJ. December 29, 2021. Citing recent evidence, experts in rehabilitation research advocate for integrating exercise into the care plans of persons with multiple sclerosis. The central role of the neurologist in clinical...
Post
Three days of remdesivir cuts risk for severe COVID-19 in outpatients
Credit: Unsplash/CC0 Public Domain A three-day course of remdesivir results in a lower risk for hospitalization or death compered with placebo among nonhospitalized patients at high risk for COVID-19 progression, according to a study published online Dec. 22 in the New England Journal of Medicine. Robert L. Gottlieb, M.D., Ph.D., from the Baylor University Medical Center...